Apellis Pharmaceuticals, Inc

(NASDAQ:APLS)

Latest On Apellis Pharmaceuticals, Inc (APLS):

Date/Time Type Description Signal Details
2023-05-25 17:48 ESTNewsApellis and Sobi to drop ALS candidate on Phase 2 setbackN/A
2023-05-18 17:01 ESTNewsApellis Pharmaceuticals: Biotech's Rising Star In C3 Inhibition SpaceN/A
2023-05-06 12:27 ESTNewsApellis Pharmaceuticals, Inc. 2023 Q1 - Results - Earnings Call PresentationN/A
2023-05-06 12:27 ESTNewsApellis Pharmaceuticals, Inc. (APLS) Q1 2023 Earnings Call TranscriptN/A
2023-05-04 22:14 ESTNewsApellis Pharmaceuticals: Maintain 'Buy' Following Astellas' $5.9 Billion Acquisition Of Iveric BioN/A
2023-05-04 22:14 ESTNewsApellis Pharmaceuticals GAAP EPS of -$1.56 misses by $0.10, revenue of $44.84M beats by $18.74MN/A
2023-05-03 20:58 ESTNewsApellis Pharmaceuticals Q1 2023 Earnings PreviewN/A
2023-05-01 19:14 ESTNewsApellis weakness on Iveric Bio takeout is buying opportunity - analystN/A
2023-05-01 06:55 ESTNewsApellis Pharmaceuticals (APLS) Presents at the Association for Research in Vision and Ophthalmology Annual Meeting - SlideshowN/A
2023-04-03 17:26 ESTNewsApellis Pharmaceuticals may be worth $90-$100 a share in sale - analystN/A
2023-04-02 23:22 ESTNewsApellis Pharmaceuticals sees takeover interest from large pharma - BloombergN/A
2023-03-24 22:48 ESTNewsApellis Pharmaceuticals Is Poised For Dominance In Geographic Atrophy MarketN/A
2023-03-16 14:19 ESTNewsApellis Pharmaceuticals' Empaveli sNDA action date extended by FDAN/A
2023-02-23 11:44 ESTNewsApellis Pharmaceuticals prices $350M in stock offeringN/A
2023-02-22 09:58 ESTNewsApellis Pharmaceuticals to raise $300M in stock and warrants offeringN/A
2023-02-21 21:29 ESTNewsApellis Pharmaceuticals GAAP EPS of -$1.50 beats by $0.06, revenue of $22.66M misses by $1.86MN/A
2023-02-18 02:43 ESTNewsApellis wins FDA nod for eye disorder therapyN/A
2023-01-27 18:43 ESTNewsApellis: Empaveli Ought To Win Approval For Eye Disease In February - The Future Looks BrightN/A
2023-01-21 14:26 ESTNewsStocks To Watch: Earnings Heat Up, Healthcare Catalysts And M&A WildcardsN/A
2023-01-05 20:02 ESTNewsApellis appoints Baumal as Chief Medical OfficerN/A
2023-01-04 02:30 ESTNewsApellis, Arvinas lower as Wells Fargo downgrades in 2023 biotech previewN/A
2022-12-15 23:44 ESTNewsApellis Pharmaceuticals: Approval Is Baked Into ValuationN/A
2022-11-18 10:24 ESTNewsApellis surges 17% as FDA accepts to review new data in filing for eye disorder drugN/A
2022-11-11 06:07 ESTNewsApellis, IVERIC bio cut to Hold at Jefferies; says Street overestimates GA marketN/A
2022-11-08 08:01 ESTNewsApellis Pharmaceuticals GAAP EPS of -$1.75 misses by $0.29, revenue of $22.05M beats by $0.46MN/A
2022-11-08 08:00 ESTNewsApellis Pharmaceuticals, Inc. (APLS) Q3 2022 Earnings Call TranscriptN/A
2022-11-05 08:22 ESTNewsApellis Pharmaceuticals Q3 2022 Earnings PreviewN/A
2022-11-03 23:08 ESTNewsApellis sinks 20% as FDA review period for eye disease drug extendsN/A
2022-10-16 23:00 ESTNewsCiti lists four more value-creating events in biotech for this yearN/A
2022-09-29 06:33 ESTNewsApellis Pharmaceuticals: Trying To Develop A Blockbuster FranchiseN/A
2022-09-08 07:22 ESTNewsApellis gains as FDA says AdCom unnecessary for eye disease candidateN/A
2022-08-24 16:51 ESTNewsApellis stock dips amid 2-year data of pegcetacoplan for eye disorderN/A
2022-08-09 18:37 ESTNewsApellis Pharmaceuticals, Inc. 2022 Q2 - Results - Earnings Call PresentationN/A
2022-08-09 18:37 ESTNewsApellis Pharmaceuticals, Inc. (APLS) CEO Cedric Francois on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-08 18:56 ESTNewsApellis Pharmaceuticals GAAP EPS of -$1.46 misses by $0.09, revenue of $16.32M misses by $0.63MN/A
2022-08-06 06:05 ESTNewsApellis Pharmaceuticals Q2 2022 Earnings PreviewN/A
2022-07-27 15:50 ESTNewsApellis to exchange $75.6M in convertible senior notes for common stockN/A
2022-07-20 18:36 ESTNewsApellis Pharmaceuticals: The Meaning Of Priority Review For Pegcetacoplan For Geographic AtrophyN/A
2022-07-20 03:57 ESTNewsWainwright sees blockbuster potential for Apellis eye degeneration therapy; shares up 22%N/A
2022-07-19 13:21 ESTNewsApellis stock soars 24% as FDA grants priority review to pegcetacoplan for eye disorderN/A
2022-07-19 13:19 ESTNewsH.C. Wainwright sees blockbuster potential for Apellis' treatment in eye degenerationN/A
2022-06-25 15:25 ESTNewsApellis: Mixed Data, But Definitely Approvable In GAN/A
2022-06-13 19:55 ESTNewsHot Stocks: APLS & SKIL both gain, TSLA declined despite upgrade, and VLTA plungedN/A
2022-06-10 11:34 ESTNewsApellis/Sobi Empaveli shows benefit in rare blood disorder patients in new analysesN/A
2022-06-01 11:05 ESTNewsApellis files for FDA approval of pegcetacoplan to treat eye disorderN/A
2022-05-06 19:17 ESTNewsApellis Pharmaceuticals, Inc. 2022 Q1 - Results - Earnings Call PresentationN/A
2022-05-06 19:15 ESTNewsApellis Pharmaceuticals (APLS) Investor Presentation - SlideshowN/A
2022-05-04 22:43 ESTNewsApellis Pharmaceuticals GAAP EPS of -$1.42 misses by $0.12, revenue of $12.1M misses by $0.52MN/A
2022-05-04 22:42 ESTNewsApellis Pharmaceuticals, Inc. (APLS) CEO Cedric Francois on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-04 03:15 ESTNewsApellis Pharmaceuticals Q1 2022 Earnings PreviewN/A

About Apellis Pharmaceuticals, Inc (APLS):

Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. Its lead product candidate is pegcetacoplan that is in Phase III clinical trials for the treatment of geographic atrophy in age-related macular degeneration and paroxysmal nocturnal hemoglobinuria (PNH) diseases; cold agglutinin disease; C3 glomerulopathy; and other glomerular diseases, such as IgA nephropathy, primary membranous nephropathy, and lupus nephritis. The company also develops APL-9, which is in single ascending dose Phase I randomized, double-blind, and placebo-controlled clinical trials for the prevention of immune system activation coincident with adeno-associated virus for intravenous administration, as well as is in Phase I/II clinical trial for acute respiratory distress syndrome. It has a collaboration and license agreement with Swedish Orphan Biovitrum AB (publ) to co-develop pegcetacoplan. The company was incorporated in 2009 and is based in Waltham, Massachusetts.

See Advanced Chart

General

  • Name Apellis Pharmaceuticals, Inc
  • Symbol APLS
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 374
  • Fiscal Year EndDecember
  • IPO Date2017-11-09
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.apellis.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 13.99
  • Price/Book (Most Recent Quarter) 18.33
  • Enterprise Value Revenue 12.97
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$6.46
  • Next Year EPS Estimate -$5.31
  • Next Quarter EPS Estimate -$1.60
  • Profit Margin -138%
  • Operating Margin -85%
  • Return on Assets -20%
  • Return on Equity -289%
  • Revenue 250.65 million
  • Earnings Per Share -$3.32
  • Revenue Per Share $3.34
  • Gross Profit -74325000
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 3.54 billion
  • Analyst Target Price $64.14
  • Book Value Per Share $2.69
View More

Share Statistics

  • Shares Outstanding 80.38 million
  • Shares Float 59.7 million
  • % Held by Insiders 2117%
  • % Held by Institutions 82.85%
  • Shares Short 8.11 million
  • Shares Short Prior Month 7.75 million
  • Short Ratio 13.44
  • Short % of Float 15%
  • Short % of Shares Outstanding 10%
View More

Technicals

  • Beta 1.52
  • 52 Week High $58.47
  • 52 Week Low $21.84
  • 50 Day Moving Average 46.47
  • 200 Day Moving Average 42.62
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Apellis Pharmaceuticals, Inc (APLS) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Apellis Pharmaceuticals, Inc (APLS) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$N/A$0.93-$0.45304.58%
2020-09-302020-11-02$646000-$1.79-$1.58-13.31%
2020-06-302020-07-30$N/A-$1.57-$1.34-17.56%
2020-03-312020-04-29$N/A-$2.29-$1.39-64.72%
2019-12-312020-02-27$N/A-$1.77-$1.14-55%
2019-09-302019-11-05$N/A-$1.10-$1.03-6.44%
2019-06-302019-07-31$N/A-$1.12-$0.78-44.39%
2019-03-312019-05-07$N/A-$0.87-$0.68-27.49%
2018-12-312019-02-26$N/A-$0.65-$0.707.58%
2018-09-302018-11-13$N/A-$0.64-$0.697.02%
2018-06-302018-07-31$N/A-$0.61-$0.42-45.86%
2018-03-312018-04-30$N/A-$0.43-$0.27-57.28%
2017-12-312018-03-19$N/A-$0.61-$0.27-129.32%
2017-09-302017-12-20$N/A-$0.23-$0.242.75%

Apellis Pharmaceuticals, Inc (APLS) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Apellis Pharmaceuticals, Inc (APLS) Chart:

Apellis Pharmaceuticals, Inc (APLS) News:

Below you will find a list of latest news for Apellis Pharmaceuticals, Inc (APLS) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Apellis Pharmaceuticals, Inc (APLS) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-12-19110CALL0 00TRUE00
2025-12-19120CALL0 00TRUE00
2025-12-19130CALL0 00TRUE00
2025-12-19140CALL0 00TRUE00
2025-12-19150CALL0 00TRUE00
2025-12-19160CALL0 00TRUE00
2025-12-19170CALL0 00TRUE00
2025-12-19183.8CALL0 10TRUE00
2025-12-19190CALL0 0110.37TRUE00
2025-12-19204.65CALL1 642130.78TRUE4.650
2025-12-19213.25CALL0 122102.47TRUE00
2025-12-19222.5CALL0 78171.94TRUE00
2025-12-19231.4CALL0 4842.36TRUE00
2025-12-19241.8CALL1 2586.26TRUE1.80
2025-12-19250.72CALL1 29649.29FALSE0.220.44
2025-12-19260.3CALL1 3445.99FALSE-0.05-0.14
2025-12-19270.25CALL0 465.26FALSE00
2025-12-19280.1CALL0 39120.88FALSE00
2025-12-19291.51CALL0 1102.35FALSE00
2025-12-19300.1CALL0 34171.15FALSE00
2025-12-19310.05CALL0 3169.42FALSE00
2025-12-19320CALL0 0183.36FALSE00
2025-12-19330CALL0 0196.47FALSE00
2025-12-19340CALL0 0208.86FALSE00
2025-12-19350.1CALL0 60257.34FALSE00
2025-12-19360CALL0 0298.73FALSE00
2025-12-19370CALL0 0280.54FALSE00
2025-12-19380CALL0 0321.66FALSE00
2025-12-19390.25CALL0 10319.57FALSE00
2025-12-19400CALL0 0329.73FALSE00
2025-12-19410CALL0 0330.52FALSE00
2025-12-19450CALL0 0356.31FALSE00
2025-12-19110PUT0 0585.75FALSE00
2025-12-19120PUT0 0526.78FALSE00
2025-12-19130PUT0 0488.65FALSE00
2025-12-19140.05PUT0 1446.01FALSE00
2025-12-19150.04PUT0 2200.69FALSE00
2025-12-19160.25PUT0 11265.92FALSE00
2025-12-19170PUT0 0245.45FALSE00
2025-12-19180.55PUT0 15211.36FALSE00
2025-12-19190.4PUT0 26172.38FALSE00
2025-12-19200.6PUT0 536188.66FALSE00
2025-12-19211PUT0 0162.06FALSE00
2025-12-19220.3PUT0 104135.72FALSE00
2025-12-19230.8PUT0 2250105.09FALSE00
2025-12-19240PUT0 085.14FALSE00
2025-12-19251.45PUT0 158.79TRUE00
2025-12-19264PUT0 060TRUE00
2025-12-19276.35PUT0 154.04TRUE00
2025-12-19280PUT0 085.39TRUE00
2025-12-19292.55PUT0 4100.8TRUE00
2025-12-19300PUT0 0114.98TRUE00
2025-12-19310PUT0 0100.13TRUE00
2025-12-19320PUT0 0127.32TRUE00
2025-12-19330PUT0 0138.41TRUE00
2025-12-19340PUT0 0148.95TRUE00
2025-12-19350PUT0 0150.35TRUE00
2025-12-19360PUT0 0168.57TRUE00
2025-12-19379.5PUT0 10168.55TRUE00
2025-12-19380PUT0 0177.11TRUE00
2025-12-19390PUT0 0185.35TRUE00
2025-12-19400PUT0 0181.67TRUE00
2025-12-19410PUT0 00TRUE00
2025-12-19450PUT0 0249.92TRUE00
2026-01-16100CALL0 0140.92TRUE00
2026-01-16110CALL0 0125.83TRUE00
2026-01-161216.66CALL0 1112.12TRUE00
2026-01-16130CALL0 899.54TRUE00
2026-01-16140CALL0 00TRUE00
2026-01-16158CALL0 410TRUE00
2026-01-16164.9CALL0 270TRUE00
2026-01-161710.09CALL0 5989.64TRUE00
2026-01-16183.8CALL0 1410TRUE00
2026-01-16199.45CALL0 270TRUE00
2026-01-16205.5CALL1 1052774.28TRUE0.530.11
2026-01-16211.75CALL0 18842.44TRUE00
2026-01-1622.53CALL0 164548.18TRUE00
2026-01-16241.87CALL0 21360.52TRUE00
2026-01-16252.2CALL15 379069.61FALSE2.20
2026-01-16261.01CALL0 52857.53FALSE00
2026-01-16271.05CALL2 56357.32FALSE1.050
2026-01-16280.9CALL3 17761.73FALSE0.210.3
2026-01-16290.35CALL0 35552.26FALSE00
2026-01-16300.45CALL1 173659.28FALSE0.050.13
2026-01-16310.53CALL0 6674.99FALSE00
2026-01-16320.25CALL5 4060.48FALSE0.250
2026-01-16330.4CALL0 2392.04FALSE00
2026-01-16341.1CALL0 30797.89FALSE00
2026-01-16350.35CALL0 161071.6FALSE00
2026-01-16360CALL0 0108.73FALSE00
2026-01-16370CALL0 0113.78FALSE00
2026-01-16380CALL0 0118.6FALSE00
2026-01-16390CALL0 0165.83FALSE00
2026-01-16400.06CALL0 1048283.82FALSE00
2026-01-16410CALL0 0131.95FALSE00
2026-01-16450.05CALL0 422147.61FALSE00
2026-01-16500.05CALL0 359128.58FALSE00
2026-01-16550.95CALL0 171179.34FALSE00
2026-01-16602.05CALL0 1182153.17FALSE00
2026-01-16650.1CALL0 271241.57FALSE00
2026-01-16700.14CALL0 343150.12FALSE00
2026-01-16750.05CALL0 55236.78FALSE00
2026-01-16800.05CALL0 186200.9FALSE00
2026-01-16850CALL0 637208.54FALSE00
2026-01-16900CALL0 84262.12FALSE00
2026-01-16950.02CALL0 24269.43FALSE00
2026-01-161000CALL0 27276.27FALSE00
2026-01-161050CALL0 96269.26FALSE00
2026-01-16100PUT0 12346.72FALSE00
2026-01-16110PUT0 0232.34FALSE00
2026-01-16120.12PUT0 5211.72FALSE00
2026-01-16130PUT0 100227.49FALSE00
2026-01-16140.45PUT0 3175.4FALSE00
2026-01-16150.45PUT0 148109.95FALSE00
2026-01-16160PUT0 0137FALSE00
2026-01-16170.65PUT0 82129.42FALSE00
2026-01-16181.2PUT0 236112.71FALSE00
2026-01-16190.28PUT0 26102.41FALSE00
2026-01-16200.5PUT0 91789.61FALSE00
2026-01-16212.4PUT0 6174.78FALSE00
2026-01-1622.50.8PUT8 75360.48FALSE0.80
2026-01-16241.4PUT403 7861.37FALSE1.40
2026-01-16251.75PUT13 62856.82TRUE-0.05-0.03
2026-01-16262.35PUT10 4457.64TRUE2.350
2026-01-16273.14PUT0 259.14TRUE00
2026-01-16283.4PUT1 33844.56TRUE-1-0.23
2026-01-16290PUT0 00TRUE00
2026-01-16306.32PUT0 132351.53TRUE00
2026-01-16318.2PUT0 146.67TRUE00
2026-01-16320PUT0 00TRUE00
2026-01-16330PUT0 00TRUE00
2026-01-16340PUT0 077.46TRUE00
2026-01-16350PUT0 6782.53TRUE00
2026-01-16360PUT0 087.38TRUE00
2026-01-16370PUT0 079.86TRUE00
2026-01-16380PUT0 084TRUE00
2026-01-16390PUT0 088TRUE00
2026-01-16400PUT0 10TRUE00
2026-01-16410PUT0 00TRUE00
2026-01-16450PUT0 00TRUE00
2026-01-165026.2PUT0 13124.64TRUE00
2026-01-165531.2PUT0 24138.15TRUE00
2026-01-16600PUT0 00TRUE00
2026-01-166539.7PUT0 00TRUE00
2026-01-167048.2PUT0 00TRUE00
2026-01-167549.9PUT0 00TRUE00
2026-01-16800PUT0 00TRUE00
2026-01-16850PUT0 00TRUE00
2026-01-16900PUT0 00TRUE00
2026-01-16950PUT0 00TRUE00
2026-01-161000PUT0 00TRUE00
2026-01-161050PUT0 00TRUE00
2026-04-17100CALL0 086.52TRUE00
2026-04-171112CALL0 2800TRUE00
2026-04-17120CALL0 067.64TRUE00
2026-04-17130CALL0 070.32TRUE00
2026-04-17147CALL0 169.83TRUE00
2026-04-17157CALL0 2867.89TRUE00
2026-04-17166.76CALL0 462.84TRUE00
2026-04-17170CALL0 067.26TRUE00
2026-04-17184.95CALL0 30264.47TRUE00
2026-04-17193.74CALL0 363.85TRUE00
2026-04-17206CALL0 22163.45TRUE00
2026-04-17215.21CALL0 1366.4TRUE00
2026-04-17225.5CALL5 10466.97TRUE5.50
2026-04-17234.7CALL0 2562.89TRUE00
2026-04-17242.6CALL0 461.07TRUE00
2026-04-17252.5CALL0 6464.69FALSE00
2026-04-17263.5CALL50 24064.87FALSE3.50
2026-04-17271.75CALL0 1766.52FALSE00
2026-04-17281.65CALL0 1064.16FALSE00
2026-04-17290CALL0 061.18FALSE00
2026-04-17302.25CALL151 50865.48FALSE0.350.18
2026-04-17311.62CALL0 3264.96FALSE00
2026-04-17321.26CALL0 662.98FALSE00
2026-04-17331CALL0 762.83FALSE00
2026-04-17341.2CALL0 660.13FALSE00
2026-04-17350.65CALL0 358.3FALSE00
2026-04-17361.6CALL0 161.8FALSE00
2026-04-17370.65CALL0 276.11FALSE00
2026-04-17380.65CALL0 378.94FALSE00
2026-04-17390.55CALL0 480.06FALSE00
2026-04-17402CALL0 461.39FALSE00
2026-04-17410.5CALL0 10109.09FALSE00
2026-04-17450.45CALL0 2077.79FALSE00
2026-04-17100.65PUT0 2136.89FALSE00
2026-04-17110.7PUT0 6124.76FALSE00
2026-04-17120.8PUT0 10113.77FALSE00
2026-04-17130.5PUT0 5112.31FALSE00
2026-04-17140PUT0 0108.08FALSE00
2026-04-17151.4PUT0 5103.57FALSE00
2026-04-17162PUT0 14130.25FALSE00
2026-04-17171.95PUT0 890.48FALSE00
2026-04-17182.57PUT0 140581.15FALSE00
2026-04-17191.3PUT0 285.04FALSE00
2026-04-17202.3PUT0 1171.27FALSE00
2026-04-17213.2PUT0 3864.74FALSE00
2026-04-17224PUT0 5763.15FALSE00
2026-04-17235.2PUT0 1265.07FALSE00
2026-04-17242.15PUT0 667.8FALSE00
2026-04-17255.5PUT0 4070.06TRUE00
2026-04-17264.21PUT1 164.45TRUE4.210
2026-04-17273.5PUT0 1865.63TRUE00
2026-04-17280PUT0 065.5TRUE00
2026-04-17297.05PUT0 164.79TRUE00
2026-04-173011.28PUT0 30159.9TRUE00
2026-04-173111.9PUT0 260.64TRUE00
2026-04-17327.1PUT0 263.79TRUE00
2026-04-17337.3PUT0 155.33TRUE00
2026-04-17340PUT0 062.05TRUE00
2026-04-17350PUT0 058.47TRUE00
2026-04-17360PUT0 062.75TRUE00
2026-04-17370PUT0 063.12TRUE00
2026-04-17380PUT0 061.73TRUE00
2026-04-17390PUT0 062.8TRUE00
2026-04-17400PUT0 061.91TRUE00
2026-04-17410PUT0 062.36TRUE00
2026-04-17450PUT0 058.54TRUE00
2026-07-17120CALL0 071.99TRUE00
2026-07-17130CALL0 066.74TRUE00
2026-07-17140CALL0 069.1TRUE00
2026-07-17150CALL0 069.63TRUE00
2026-07-17160CALL0 071.56TRUE00
2026-07-17170CALL0 067.84TRUE00
2026-07-17180CALL0 068.07TRUE00
2026-07-17190CALL0 069.39TRUE00
2026-07-17200CALL0 067.36TRUE00
2026-07-17210CALL0 067.38TRUE00
2026-07-17220CALL0 066.87TRUE00
2026-07-17230CALL0 068.07TRUE00
2026-07-17240CALL0 067.35TRUE00
2026-07-17250CALL0 064.21FALSE00
2026-07-17260CALL0 063.46FALSE00
2026-07-17270CALL0 059.74FALSE00
2026-07-17280CALL0 062.86FALSE00
2026-07-17290CALL0 071.47FALSE00
2026-07-17300CALL0 061.88FALSE00
2026-07-17310CALL0 059.76FALSE00
2026-07-17120PUT0 0101.4FALSE00
2026-07-17130PUT0 0125.68FALSE00
2026-07-17140PUT0 0121.49FALSE00
2026-07-17150PUT0 0117.28FALSE00
2026-07-17160PUT0 080.4FALSE00
2026-07-17172.1PUT0 175.34FALSE00
2026-07-17180PUT0 071.84FALSE00
2026-07-17190PUT0 068.65FALSE00
2026-07-17203.6PUT0 2074.09FALSE00
2026-07-17214PUT0 2072.81FALSE00
2026-07-17223.9PUT0 2060.27FALSE00
2026-07-17233.4PUT1 061.99FALSE3.40
2026-07-17244.4PUT0 1069.32FALSE00
2026-07-17250PUT0 067TRUE00
2026-07-17260PUT0 067.05TRUE00
2026-07-17270PUT0 062.78TRUE00
2026-07-17280PUT0 062.12TRUE00
2026-07-17290PUT0 069.6TRUE00
2026-07-17300PUT0 060.4TRUE00
2026-07-17310PUT0 062.03TRUE00
2027-01-15515.1CALL0 481.84TRUE00
2027-01-151016.08CALL1 2278.39TRUE16.080
2027-01-15130CALL0 070.73TRUE00
2027-01-15159.05CALL0 228768.13TRUE00
2027-01-15180CALL0 068.98TRUE00
2027-01-15206.1CALL0 8466.7TRUE00
2027-01-15237.5CALL1 7461.8TRUE7.50
2027-01-15255CALL0 6863.44FALSE00
2027-01-15288.35CALL0 762.31FALSE00
2027-01-15303.3CALL0 21960.35FALSE00
2027-01-15334.1CALL0 459.6FALSE00
2027-01-15351.5CALL0 256157.55FALSE00
2027-01-15370CALL0 056.38FALSE00
2027-01-15402.5CALL1 25257.28FALSE2.50
2027-01-15421.4CALL0 269056.76FALSE00
2027-01-15450.86CALL0 5359.09FALSE00
2027-01-15472.43CALL0 162.1FALSE00
2027-01-15502.5CALL0 4153.09FALSE00
2027-01-15550.52CALL0 39964.36FALSE00
2027-01-1550PUT0 0278.07FALSE00
2027-01-15100.7PUT0 1153.25FALSE00
2027-01-15130PUT0 0125.86FALSE00
2027-01-15152.6PUT0 19976.86FALSE00
2027-01-15180PUT0 068.26FALSE00
2027-01-15202.65PUT0 11670.23FALSE00
2027-01-15235.55PUT0 364.25FALSE00
2027-01-15256PUT0 37562.17TRUE00
2027-01-15286.41PUT0 561.8TRUE00
2027-01-15309.1PUT0 88460.23TRUE00
2027-01-153316.37PUT0 560.94TRUE00
2027-01-153516.71PUT0 63758.14TRUE00
2027-01-15370PUT0 057.64TRUE00
2027-01-15400PUT0 056.04TRUE00
2027-01-15420PUT0 258.16TRUE00
2027-01-15450PUT0 055.41TRUE00
2027-01-15470PUT0 053.28TRUE00
2027-01-15500PUT0 057.88TRUE00
2027-01-15550PUT0 060.53TRUE00
2028-01-21100CALL0 065.96TRUE00
2028-01-211310.5CALL0 163.46TRUE00
2028-01-21150CALL0 061.69TRUE00
2028-01-21180CALL0 061.7TRUE00
2028-01-212010.5CALL0 761.55TRUE00
2028-01-21220CALL0 060.27TRUE00
2028-01-21258.25CALL0 161.72FALSE00
2028-01-21277.19CALL0 260.83FALSE00
2028-01-21309.6CALL0 359.76FALSE00
2028-01-21320CALL0 058.06FALSE00
2028-01-21355.5CALL0 84254.87FALSE00
2028-01-21370CALL0 058.77FALSE00
2028-01-21403.71CALL0 157.41FALSE00
2028-01-21450CALL0 055.84FALSE00
2028-01-21100PUT0 0141.01FALSE00
2028-01-21130PUT0 072.7FALSE00
2028-01-21153.3PUT0 361.87FALSE00
2028-01-21180PUT0 060.85FALSE00
2028-01-21200PUT0 058.58FALSE00
2028-01-21220PUT0 060.14FALSE00
2028-01-21250PUT0 059.99TRUE00
2028-01-21270PUT0 057.98TRUE00
2028-01-21300PUT0 057.92TRUE00
2028-01-21320PUT0 058.56TRUE00
2028-01-21350PUT0 057.05TRUE00
2028-01-21370PUT0 056.79TRUE00
2028-01-21400PUT0 057.7TRUE00
2028-01-21450PUT0 056.58TRUE00

Latest APLS Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST5$39.4
Jun 13, 2022 7:59 PM EST25$39.4
Jun 13, 2022 7:59 PM EST86$39.39
Jun 13, 2022 7:59 PM EST14$39.4
Jun 13, 2022 7:59 PM EST32$39.4

Apellis Pharmaceuticals, Inc (APLS) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220021048/0001127602-20-021048-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1492422/000083423720004741/0000834237-20-004741-index.htm
2020-02-053/AInitial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320003295/0000899243-20-003295-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004260/0000899243-20-004260-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004262/0000899243-20-004262-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004264/0000899243-20-004264-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004268/0000899243-20-004268-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004275/0000899243-20-004275-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004281/0000899243-20-004281-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004288/0000899243-20-004288-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004299/0000899243-20-004299-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004303/0000899243-20-004303-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004312/0000899243-20-004312-index.htm
2020-02-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320004314/0000899243-20-004314-index.htm
2020-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320008068/0000899243-20-008068-index.htm
2020-10-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320027595/0000899243-20-027595-index.htm
2020-10-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000089924320027598/0000899243-20-027598-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1492422/000090221920000352/0000902219-20-000352-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1492422/000090266420001196/0000902664-20-001196-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1492422/000092963820000336/0000929638-20-000336-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm
2020-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220006429/0001127602-20-006429-index.htm
2020-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220011988/0001127602-20-011988-index.htm
2020-04-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220013334/0001127602-20-013334-index.htm
2020-04-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220013338/0001127602-20-013338-index.htm
2020-04-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220014098/0001127602-20-014098-index.htm
2020-04-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220014100/0001127602-20-014100-index.htm
2020-04-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220014554/0001127602-20-014554-index.htm
2020-05-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220016304/0001127602-20-016304-index.htm
2020-05-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220017178/0001127602-20-017178-index.htm
2020-05-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220017181/0001127602-20-017181-index.htm
2020-06-093Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220019258/0001127602-20-019258-index.htm
2020-06-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220019731/0001127602-20-019731-index.htm
2020-06-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220019733/0001127602-20-019733-index.htm
2020-06-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220019735/0001127602-20-019735-index.htm
2020-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220021048/0001127602-20-021048-index.htm
2020-07-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220021646/0001127602-20-021646-index.htm
2020-08-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220022885/0001127602-20-022885-index.htm
2020-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220023992/0001127602-20-023992-index.htm
2020-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220024043/0001127602-20-024043-index.htm
2020-09-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220024640/0001127602-20-024640-index.htm
2020-09-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220025183/0001127602-20-025183-index.htm
2020-10-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220026264/0001127602-20-026264-index.htm
2020-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220026748/0001127602-20-026748-index.htm
2020-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220026750/0001127602-20-026750-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220027098/0001127602-20-027098-index.htm
2020-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220027101/0001127602-20-027101-index.htm
2020-11-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1492422/000112760220027991/0001127602-20-027991-index.htm
2020-02-27S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1492422/000119312520052855/0001193125-20-052855-index.htm
2020-02-27S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1492422/000119312520052867/0001193125-20-052867-index.htm
2020-04-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492422/000119312520098977/0001193125-20-098977-index.htm
2020-04-22DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1492422/000119312520115068/0001193125-20-115068-index.htm
2020-04-22DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1492422/000119312520115084/0001193125-20-115084-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492422/000119312520135621/0001193125-20-135621-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492422/000119312520141579/0001193125-20-141579-index.htm
2020-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492422/000119312520157384/0001193125-20-157384-index.htm
2020-10-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1492422/000119312520277496/0001193125-20-277496-index.htm
2010-05-19DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1492242/000149224210000001/0001492242-10-000001-index.htm
2020-02-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1492422/000156459020007350/0001564590-20-007350-index.htm
2020-04-2910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1492422/000156459020019689/0001564590-20-019689-index.htm
2020-07-3010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1492422/000156459020034763/0001564590-20-034763-index.htm
2020-11-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1492422/000156459020049423/0001564590-20-049423-index.htm
2020-08-24CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1492422/999999999720004458/9999999997-20-004458-index.htm

Apellis Pharmaceuticals, Inc (APLS) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Apellis Pharmaceuticals, Inc (APLS). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 2117%
Institutional Ownership: 8285%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-02-13Pascal DeschateletsChief Operating OfficerSell55,398.0040.982,270,154.641,008,681.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm
2020-02-18Cedric FrancoisChief Executive OfficerSell5,000.0040.67203,330.001,027,430.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm
2020-02-18Cedric FrancoisChief Executive OfficerSell30,637.0040.661,245,792.331,032,430.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell300.0023.867,158.001,053,067.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell3,212.0022.2871,556.941,053,367.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell15,065.0021.58325,087.641,056,579.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-02-19Cedric FrancoisChief Executive OfficerBuy30,637.002.1465,563.181,058,067.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm
2020-02-18Cedric FrancoisChief Executive OfficerBuy30,637.002.1465,563.181,063,067.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220006654/0001127602-20-006654-index.htm
2020-02-13Pascal DeschateletsChief Operating OfficerBuy117,205.002.14250,818.701,064,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm
2020-02-10Cedric FrancoisChief Executive OfficerBuy34,375.001,066,805.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004299/0000899243-20-004299-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell12,060.0020.69249,557.581,071,644.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-10-15Cedric FrancoisChief Executive OfficerSell5,000.0034.46172,300.001,083,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220027098/0001127602-20-027098-index.htm
2020-03-17Cedric FrancoisChief Executive OfficerBuy30,637.002.1465,563.181,083,704.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell700.0022.2915,600.201,083,704.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell2,192.0021.5747,279.251,084,404.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerSell2,108.0020.7343,694.621,086,596.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-09-15Cedric FrancoisChief Executive OfficerSell5,000.0030.96154,800.001,088,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220025183/0001127602-20-025183-index.htm
2020-03-16Cedric FrancoisChief Executive OfficerBuy30,637.002.1465,563.181,088,704.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011263/0001127602-20-011263-index.htm
2020-08-20Cedric FrancoisChief Executive OfficerSell3,457.0030.00103,710.001,093,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220024043/0001127602-20-024043-index.htm
2020-08-18Cedric FrancoisChief Executive OfficerSell1,543.0030.0046,290.001,096,536.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220023992/0001127602-20-023992-index.htm
2020-07-15Cedric FrancoisChief Executive OfficerSell5,000.0032.12160,600.001,098,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220021646/0001127602-20-021646-index.htm
2020-06-15Cedric FrancoisChief Executive OfficerSell5,000.0030.21151,050.001,103,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220019731/0001127602-20-019731-index.htm
2020-05-15Cedric FrancoisChief Executive OfficerSell5,000.0029.92149,600.001,108,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220017181/0001127602-20-017181-index.htm
2020-04-15Cedric FrancoisChief Executive OfficerSell5,000.0029.77148,850.001,113,079.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220014100/0001127602-20-014100-index.htm
2020-02-10LUKAS SCHEIBLEROfficerBuy9,375.0012,310.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004314/0000899243-20-004314-index.htm
2020-10-07Victoria L. BrownProgram Team LeadBuy12,000.0018.98227,760.0015,607.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220026748/0001127602-20-026748-index.htm
2020-02-10Timothy Eugene SullivanChief Financial OfficerBuy11,688.0023,387.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004303/0000899243-20-004303-index.htm
2020-02-10Nicole D PerryVice President - FinanceBuy2,500.002,500.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004275/0000899243-20-004275-index.htm
2020-02-10Ahmad SadrOfficerBuy2,725.002,725.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004264/0000899243-20-004264-index.htm
2020-11-02Federico GrossiCHIEF MEDICAL OFFICERSell600.0031.0918,654.0027,725.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220027991/0001127602-20-027991-index.htm
2020-10-01Federico GrossiOfficerSell600.0030.2218,132.0028,325.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220026264/0001127602-20-026264-index.htm
2020-09-01Federico GrossiOfficerSell600.0031.5818,948.0028,925.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220024640/0001127602-20-024640-index.htm
2020-08-03Federico GrossiOfficerSell600.0026.2815,768.0029,525.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220022885/0001127602-20-022885-index.htm
2020-07-01Federico GrossiOfficerSell850.0032.4327,565.5030,125.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220021048/0001127602-20-021048-index.htm
2020-06-15Federico GrossiOfficerSell856.0030.2125,859.7630,975.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220019735/0001127602-20-019735-index.htm
2020-02-10Federico GrossiOfficerBuy9,375.0031,831.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004262/0000899243-20-004262-index.htm
2020-02-10David O. WatsonGeneral CounselSell5,000.0044.50222,500.0035,417.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004260/0000899243-20-004260-index.htm
2020-10-07Victoria L. BrownProgram Team LeadSell12,000.0035.00420,000.003,607.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220026748/0001127602-20-026748-index.htm
2020-02-10David O. WatsonGeneral CounselBuy6,375.0040,417.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004260/0000899243-20-004260-index.htm
2020-02-10David O. WatsonGeneral CounselBuy7,505.002.6720,038.3542,922.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004260/0000899243-20-004260-index.htm
2020-05-08PAUL R. FONTEYNEDirectorBuy5,000.0031.81159,034.005,000.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220016304/0001127602-20-016304-index.htm
2020-02-10Lucia CelonaOfficerBuy5,213.005,213.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004281/0000899243-20-004281-index.htm
2020-02-14Alec MachielsDirectorSell2,500.0042.35105,875.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220006429/0001127602-20-006429-index.htm
2020-03-25Alec MachielsDirectorSell2,500.0030.0075,000.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011988/0001127602-20-011988-index.htm
2020-04-15Alec MachielsDirectorSell2,500.0030.0075,000.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220014098/0001127602-20-014098-index.htm
2020-05-15Alec MachielsDirectorSell2,500.0030.0075,000.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220017178/0001127602-20-017178-index.htm
2020-06-15Alec MachielsDirectorSell2,500.0030.2175,525.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220019733/0001127602-20-019733-index.htm
2020-10-07Alec MachielsDirectorSell7,500.0035.00262,500.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220026750/0001127602-20-026750-index.htm
2020-10-15Alec MachielsDirectorSell2,500.0035.0087,500.00669,544.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220027101/0001127602-20-027101-index.htm
2020-02-14Alec MachielsDirectorBuy2,500.002.676,675.00672,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220006429/0001127602-20-006429-index.htm
2020-03-25Alec MachielsDirectorBuy2,500.002.676,675.00672,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220011988/0001127602-20-011988-index.htm
2020-04-15Alec MachielsDirectorBuy2,500.002.676,675.00672,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220014098/0001127602-20-014098-index.htm
2020-05-15Alec MachielsDirectorBuy2,500.002.676,675.00672,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220017178/0001127602-20-017178-index.htm
2020-06-15Alec MachielsDirectorBuy2,500.002.676,675.00672,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220019733/0001127602-20-019733-index.htm
2020-10-15Alec MachielsDirectorBuy2,500.002.676,675.00672,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220027101/0001127602-20-027101-index.htm
2020-10-07Alec MachielsDirectorBuy7,500.002.6720,025.00677,044.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220026750/0001127602-20-026750-index.htm
2020-02-10Thomas A. LacknerOfficerBuy2,725.007,725.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004268/0000899243-20-004268-index.htm
2020-02-10Pascal DeschateletsChief Operating OfficerBuy9,375.00891,118.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004312/0000899243-20-004312-index.htm
2020-02-10Adam J. TownsendOfficerBuy9,375.009,375.00https://www.sec.gov/Archives/edgar/data/1492422/000089924320004288/0000899243-20-004288-index.htm
2020-02-12Pascal DeschateletsChief Operating OfficerSell52,075.0042.802,228,966.23946,874.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm
2020-02-12Pascal DeschateletsChief Operating OfficerBuy117,206.002.14250,820.84998,949.00https://www.sec.gov/Archives/edgar/data/1492422/000112760220005685/0001127602-20-005685-index.htm